Celldex Therapeutics, Inc. — Director's Dealing 2017

Mar 1, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celldex Therapeutics, Inc. (CLDX)
CIK: 0000744218
Period of Report: 2017-03-01

Reporting Person: MARINO JAMES J (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-03-01	Non-Qualified Stock Option (right to buy)	$3.56	A	8000	Acquired	2027-03-01	Common Stock (8000)	Direct

Footnotes

F1: Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan.

F2: 100% of the total amount of shares subject to the Option vests on March 1, 2018.